Better Buy: Geron vs. Celgene
Which stock wins between these two biotechs?
Editors' Picks
Investors Rejoice: U.S. Renewables Could Top Coal by 2022
A surge in wind power can blow coal down the rankings in the near future. These renewable energy stocks could benefit.
3 Stocks to Buy With Dividends Yielding More Than 4%
These three high-yield investments could deliver decades of income and market-beating returns to investors.
3 Reasons to Believe Netflix’s Incredible Cash Flow Promise
The streaming TV giant sees this year as the low mark for annual cash outflows.
Recent articles
This Dividend Growth Streak Comes to an End After 59 Consecutive Quarters
The high-yielding MLP is finally pressing the pause button after running out of fuel.
Apple TV+ Could Add $6 Billion to Services Revenue Next Year
But the company's free one-year promotion could complicate matters.
Snap Has More Competitors to Worry About Than Instagram
Mobile-focused video apps TikTok and Quibi pose a threat to Snapchat's future, too.
Is Medical Properties Trust a Buy?
Medical Properties Trust is striking while the iron is hot and growing fast, but is that good or bad for investors?
Facebook's Brand Crisis Isn't Over Yet
A decline in an annual brand ranking and Zuckerberg's bizarre free-speech address show that the company still has work to do to mend its image.
Leading Analyst Questions the Value of GE's Aviation Segment: The Lowdown
GE investors were spooked by an analyst's report that challenged the consensus view on GE Aviation's valuation. Here's what it means to investors.
Netflix Is Still on Shaky Ground After Q3 Earnings Beat
Netflix's profit skyrocketed last quarter due to moderate growth in content and marketing costs, but the company may never produce as much free cash flow as bulls expect.
Why Uber Could Sink Even Lower
Investors should brace themselves for more difficulties coming toward the ride-hailing service.
Where Will Frontier Communications Be in 1 Year?
The short answer: no place most investors would want to be.
The 3 Biggest Takeaways From Intuitive Surgical's Impressive Quarter
Sure, procedures were up -- but these factors are just as important.
Philip Morris International Beats on Earnings as IQOS Surges
A muted outlook for fourth-quarter earnings, however, keeps enthusiasm from getting overheated.
Facebook Moves Ahead With Libra Despite Some Major Setbacks
The world may not be ready for Facebook's digital token Libra, but that's not stopping the social media giant from forging ahead.
3 Dividend Stocks Ideal for Retirees
This trio of dividend-paying stocks could energize your retirement portfolio.
Investors Rejoice: U.S. Renewables Could Top Coal by 2022
A surge in wind power can blow coal down the rankings in the near future. These renewable energy stocks could benefit.
3 Stocks to Buy With Dividends Yielding More Than 4%
These three high-yield investments could deliver decades of income and market-beating returns to investors.
3 Reasons to Believe Netflix’s Incredible Cash Flow Promise
The streaming TV giant sees this year as the low mark for annual cash outflows.
Is 3M a Buy?
The industrial giant's shares are down 20% over the last year. Is this a buying opportunity, or is there more pain to come?
Better Buy: Geron vs. Celgene
Which stock wins between these two biotechs?
“Moats Are Lame”: 3 Top Investing Themes of the 2010s
With a new decade nearly here, it’s time to look back on the biggest and best investing trends of the last 10 years.
3 Important Takeaways from Atlassian's Earnings Report
The collaboration-software maker delivered solid results, but investors were looking for more.